Total Payments
$44,447
2024 Payments
$1,692
Companies
51
Transactions
672
Medicare Patients
3,305
Medicare Billing
$606,577
Payment Breakdown by Category
Other$29,201 (65.7%)
Food & Beverage$12,626 (28.4%)
Travel$2,237 (5.0%)
Education$382.85 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $29,201 | 36 | 65.7% |
| Food and Beverage | $12,626 | 618 | 28.4% |
| Travel and Lodging | $2,237 | 9 | 5.0% |
| Education | $382.85 | 9 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Avanir Pharmaceuticals, Inc. | $32,116 | 59 | $0 (2018) |
| Teva Pharmaceuticals USA, Inc. | $1,457 | 57 | $0 (2024) |
| ABBVIE INC. | $1,073 | 51 | $0 (2024) |
| Biogen, Inc. | $1,071 | 48 | $0 (2024) |
| UCB, Inc. | $732.35 | 36 | $0 (2024) |
| EMD Serono, Inc. | $642.49 | 26 | $0 (2024) |
| Lundbeck LLC | $634.63 | 27 | $0 (2024) |
| GENZYME CORPORATION | $600.65 | 36 | $0 (2023) |
| Genentech USA, Inc. | $392.57 | 22 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $392.36 | 18 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,692 | 63 | ABBVIE INC. ($293.27) |
| 2023 | $1,317 | 69 | AbbVie Inc. ($216.67) |
| 2022 | $1,086 | 58 | EMD Serono, Inc. ($172.61) |
| 2021 | $1,064 | 55 | Teva Pharmaceuticals USA, Inc. ($165.09) |
| 2020 | $344.05 | 19 | Allergan, Inc. ($56.48) |
| 2019 | $567.65 | 27 | AbbVie, Inc. ($121.47) |
| 2018 | $11,691 | 155 | Avanir Pharmaceuticals, Inc. ($9,094) |
| 2017 | $26,685 | 226 | Avanir Pharmaceuticals, Inc. ($23,022) |
All Payment Transactions
672 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | ABBVIE INC. | QULIPTA (Drug), BOTOX | Food and Beverage | In-kind items and services | $21.48 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $24.09 | General |
| Category: Musculoskeletal | ||||||
| 11/20/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $17.99 | General |
| Category: Neuroscience | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $29.00 | General |
| Category: Neurology | ||||||
| 11/13/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $20.64 | General |
| 11/11/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $15.63 | General |
| 11/04/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: PAIN | ||||||
| 10/28/2024 | Biogen, Inc. | SKYCLARYS (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: Neurology | ||||||
| 10/24/2024 | Biogen, Inc. | TYSABRI (Biological) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: Neurology | ||||||
| 10/17/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: Neuropsychiatry | ||||||
| 10/15/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: Neuroscience | ||||||
| 10/08/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $27.61 | General |
| Category: Neurology | ||||||
| 10/03/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: PSYCHIATRY | ||||||
| 10/01/2024 | Abbott Laboratories | INFINITY (Device) | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: Neuromodulation | ||||||
| 09/26/2024 | Grifols USA, LLC | Gamunex-C (Biological) | Food and Beverage | In-kind items and services | $25.28 | General |
| Category: Immunology and Neurology | ||||||
| 09/12/2024 | Boston Scientific Corporation | Vercise (Device) | Food and Beverage | In-kind items and services | $32.53 | General |
| Category: Vercise_NMD | ||||||
| 09/12/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/04/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $32.21 | General |
| Category: NEUROLOGY | ||||||
| 08/21/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 08/19/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $24.33 | General |
| Category: Neurology | ||||||
| 08/13/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $21.48 | General |
| 08/08/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: Neurology | ||||||
| 08/01/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: Rare Disease | ||||||
| 07/31/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 07/25/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 852 | 14,622 | $843,198 | $171,527 |
| 2022 | 12 | 848 | 11,850 | $774,569 | $159,847 |
| 2021 | 12 | 853 | 11,032 | $715,320 | $158,902 |
| 2020 | 12 | 752 | 7,714 | $555,002 | $116,301 |
Total Patients
3,305
Total Services
45,218
Medicare Billing
$606,577
Procedure Codes
47
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 40 | 13,605 | $312,915 | $67,645 | 21.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 244 | 244 | $150,060 | $29,389 | 19.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 265 | 343 | $162,239 | $29,160 | 18.0% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 118 | 199 | $76,018 | $16,166 | 21.3% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2023 | 47 | 47 | $44,556 | $9,317 | 20.9% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 31 | 32 | $26,080 | $5,333 | 20.4% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 23 | 43 | $24,338 | $5,249 | 21.6% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 23 | 24 | $16,272 | $3,076 | 18.9% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2023 | 18 | 42 | $12,978 | $2,701 | 20.8% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 18 | 18 | $9,342 | $2,001 | 21.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 25 | 25 | $8,400 | $1,489 | 17.7% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 28 | 10,800 | $237,600 | $51,651 | 21.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 260 | 260 | $156,260 | $31,581 | 20.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 231 | 345 | $160,770 | $29,750 | 18.5% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 128 | 205 | $77,285 | $17,360 | 22.5% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2022 | 39 | 39 | $37,323 | $8,028 | 21.5% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 32 | 32 | $26,496 | $5,547 | 20.9% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 28 | 28 | $19,320 | $3,992 | 20.7% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2022 | 29 | 30 | $15,780 | $3,406 | 21.6% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2022 | 11 | 30 | $16,440 | $3,265 | 19.9% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2022 | 19 | 38 | $11,742 | $2,292 | 19.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 19 | 19 | $7,657 | $1,518 | 19.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 24 | 24 | $7,896 | $1,458 | 18.5% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2021 | 33 | 9,986 | $219,692 | $47,095 | 21.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 274 | 274 | $161,934 | $35,098 | 21.7% |
About Dr. Eric Edgar, MD
Dr. Eric Edgar, MD is a Neurology healthcare provider based in Tulsa, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/23/2009. The National Provider Identifier (NPI) number assigned to this provider is 1972744894.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Edgar, MD has received a total of $44,447 in payments from pharmaceutical and medical device companies, with $1,692 received in 2024. These payments were reported across 672 transactions from 51 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($29,201).
As a Medicare-enrolled provider, Edgar has provided services to 3,305 Medicare beneficiaries, totaling 45,218 services with total Medicare billing of $606,577. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Neurology
- Location Tulsa, OK
- Active Since 03/23/2009
- Last Updated 11/04/2025
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1972744894
Products in Payments
- NUEDEXTA (Drug) $32,158
- AUSTEDO (Drug) $456.95
- BOTOX (Biological) $439.93
- COPAXONE (Drug) $437.89
- TYSABRI (Biological) $421.24
- NORTHERA (Drug) $407.60
- OCREVUS (Biological) $348.20
- Briviact (Drug) $336.35
- Fycompa (Drug) $318.45
- SD809-HD (Drug) $295.47
- INGREZZA (Drug) $291.08
- LEMTRADA (Drug) $275.32
- APTIOM (Drug) $274.07
- KESIMPTA (Drug) $227.05
- Fintepla (Drug) $222.38
- SPINRAZA (Biological) $221.28
- UBRELVY (Drug) $220.37
- NUPLAZID (Drug) $206.45
- QULIPTA (Drug) $198.56
- AUBAGIO (Drug) $192.50
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Tulsa
Jaclyn Duvall, Md, MD
Neurology — Payments: $1.2M
Neurology $1.2M
Tania Reyna, Md, MD
Neurology — Payments: $542,404
Neurology $542,404
Gregory Connor, M.d, M.D
Neurology — Payments: $515,386
Neurology $515,386
Mrs. Aimee Borazanci, M.d, M.D
Neurology — Payments: $200,000
Neurology $200,000
Dr. Alok Pasricha, M.d, M.D
Neurology — Payments: $155,502
Neurology $155,502
Christopher Glisson, Do, DO
Neurology — Payments: $133,446
Neurology $133,446